Tumor-Derived Pancreatic Stellate Cells Promote Pancreatic Cancer Cell Invasion Through Release of Thrombospondin-2

Journal of Surgical Research

Volumn 156, Issue 1, 2009, Pages 155-160

  Farrow, Buckminster ^a   Berger, David H ^a   Rowley, David ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

metastasis; pancreatic cancer; thrombospondin; tumor microenvironment

Indexed keywords

GROWTH FACTOR; MATRIGEL; PROTEINASE; SCLEROPROTEIN; SMALL INTERFERING RNA; THROMBOSPONDIN 2;

ARTICLE; CANCER CELL; CANCER INVASION; CELL MIGRATION; COCULTURE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN TISSUE; PANCREAS CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; QUANTITATIVE ANALYSIS; SKIN FIBROBLAST; STELLATE CELL; STROMA CELL; TUMOR CELL;

ADENOCARCINOMA; CELL LINE, TUMOR; COCULTURE TECHNIQUES; FIBROBLASTS; GENE SILENCING; HUMANS; NEOPLASM INVASIVENESS; PANCREAS; PANCREATIC NEOPLASMS; THROMBOSPONDINS;

EID: 68649125994     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2009.03.040     Document Type: Article

References (28)

1. Cheng N., Bhowmick N.A., Chytil A., et al. Loss of TGF-β type II receptor in fibroblasts promotes mammary carcinoma growth and invasion through upregulation of TGF-alpha-, MSP- and HGF-mediated signaling networks. Oncogene 24 (2005) 5053
2. Tuxhorn J.A., Ayala G.E., Smith M.J., et al. Reactive stroma in human prostate cancer: Induction of myofibroblast phenotype and extracellular matrix remodeling. Clin Cancer Res 8 (2002) 2912
3. Camacho D., Reichenbach D., Duerr G.D., et al. Value of laparoscopy in the staging of pancreatic cancer. Jop 6 (2005) 552
4. Mulcahy M.F., Wahl A.O., and Small Jr. W. The current status of combined radiotherapy and chemotherapy for locally advanced or resected pancreas cancer. J Natl Compr Cancer Netw 3 (2005) 637
5. Jemal A., Siegel R., Ward E., et al. Cancer statistics, 2008. CA. Cancer J Clin 58 (2008) 71
6. Farrow B., Sugiyama Y., Chen A., et al. Inflammatory mechanisms contributing to pancreatic cancer development. Ann Surg 239 (2004) 763 discussion 769
7. Apte M.V., Haber P.S., Darby S.J., et al. Pancreatic stellate cells are activated by proinflammatory cytokines: Implications for pancreatic fibrogenesis. Gut 44 (1999) 534
8. Farrow B., and Evers B.M. Inflammation and the development of pancreatic cancer. Surg Oncol 10 (2002) 153
9. Apte M.V., and Wilson J.S. Mechanisms of pancreatic fibrosis. Dig Dis (Basel, Switzerland) 22 (2004) 273
10. Shek F.W., Benyon R.C., Walker F.M., et al. Expression of transforming growth factor-β 1 by pancreatic stellate cells and its implications for matrix secretion and turnover in chronic pancreatitis. Am J Pathol 160 (2002) 1787
11. Hwang R.F., Moore T., Arumugam T., et al. Cancer-associated stromal fibroblasts promote pancreatic tumor progression. Cancer Res 68 (2008) 918
12. Schneiderhan W., Diaz F., Fundel M., et al. Pancreatic stellate cells are an important source of MMP-2 in human pancreatic cancer and accelerate tumor progression in a murine xenograft model and CAM assay. J Cell Sci 120 (2007) 512
13. Bachem M.G., Zhou S., Buck K., et al. Pancreatic stellate cells-role in pancreas cancer. Langenbeck's Arch Surg 393 (2008) 891
14. Hartel M., Di Mola F.F., Gardini A., et al. Desmoplastic reaction influences pancreatic cancer growth behavior. World J Surg 28 (2004) 818
15. Yoshida S., Yokota T., Ujiki M., et al. Pancreatic cancer stimulates pancreatic stellate cell proliferation and TIMP-1 production through the MAP kinase pathway. Biochem Biophys Res Comm 323 (2004) 1241
16. Koninger J., Giese T., di Mola F.F., et al. Pancreatic tumor cells influence the composition of the extracellular matrix. Biochem Biophys Res Comm 322 (2004) 943
17. Armstrong T., Packham G., Murphy L.B., et al. Type I collagen promotes the malignant phenotype of pancreatic ductal adenocarcinoma. Clin Cancer Res 10 (2004) 7427
18. Christofori G. New signals from the invasive front. Nature 441 (2006) 444
19. Bornstein P. Thrombospondins as matricellular modulators of cell function. J Clin Invest 107 (2001) 929
20. Bornstein P., Armstrong L.C., Hankenson K.D., et al. Thrombospondin 2, a matricellular protein with diverse functions. Matrix Biol 19 (2000) 557
21. Neuschwander-Tetri B.A., Talkad V., and Otis Stephen F. Induced thrombospondin expression in the mouse pancreas during pancreatic injury. Int J Biochem Cell Biol 38 (2006) 102
22. Loeffler M., Kruger J.A., Niethammer A.G., et al. Targeting tumor-associated fibroblasts improves cancer chemotherapy by increasing intratumoral drug uptake. J Clin Invest 116 (2006) 1955
23. Lu S.L., Herrington H., Reh D., et al. Loss of transforming growth factor-β type II receptor promotes metastatic head-and-neck squamous cell carcinoma. Genes Develop 20 (2006) 1331
24. Aghi M., Rabkin S.D., and Martuza R.L. Angiogenic response caused by oncolytic herpes simplex virus-induced reduced thrombospondin expression can be prevented by specific viral mutations or by administering a thrombospondin-derived peptide. Cancer Res 67 (2007) 440
25. Ordonez J.L., Paraoan L., Hiscott P., et al. Differential expression of angioregulatory matricellular proteins in posterior uveal melanoma. Melanoma Res 15 (2005) 495
26. Sawai H., Okada Y., Funahashi H., et al. Activation of focal adhesion kinase enhances the adhesion and invasion of pancreatic cancer cells via extracellular signal-regulated kinase-1/2 signaling pathway activation. Mol Cancer 4 (2005) 37
27. Grzesiak J.J., Ho J.C., Moossa A.R., et al. The integrin-extracellular matrix axis in pancreatic cancer. Pancreas 35 (2007) 293
28. Yang Z., Kyriakides T.R., and Bornstein P. Matricellular proteins as modulators of cell-matrix interactions: Adhesive defect in thrombospondin 2-null fibroblasts is a consequence of increased levels of matrix metalloproteinase-2. Mol Biol Cell 11 (2000) 3353